Clarity Pharmaceuticals Ltd (ASX:CU6)
Australia · Delayed Price · Currency is AUD 2.690
+0.010 (0.37%)
Aug 7, 2026, 4:10 PM AEST
Clarity Pharmaceuticals Market Cap
Clarity Pharmaceuticals has a market cap or net worth of 1 billion as of August 7, 2026. Its market cap has decreased by -42.09% in one year.
Market Cap
1.00B
Enterprise Value
777.34M
Revenue
10.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.69
ChartMarket Cap Chart
Since August 25, 2021, Clarity Pharmaceuticals's market cap has increased from 384.20M to 1.00B, an increase of 161.22%. That is a compound annual growth rate of 21.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 1.00B | -20.19% |
| Dec 31, 2025 | 1.26B | -6.00% |
| Dec 31, 2024 | 1.34B | 168.49% |
| Dec 29, 2023 | 498.26M | 93.82% |
| Dec 30, 2022 | 257.07M | 35.63% |
| Dec 31, 2021 | 189.54M | -50.67% |
| Aug 25, 2021 | 384.20M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 5.50B |
| Mesoblast | 2.90B |
| Neuren Pharmaceuticals | 2.88B |
| PYC Therapeutics | 2.01B |
| Clinuvel Pharmaceuticals | 476.04M |
| Tetratherix | 408.52M |
| Racura Oncology | 390.14M |
| Starpharma Holdings | 332.71M |